Development of a metabolism-associated prognostic risk model based on immune landscape stratification in prostate cancer
Our findings highlight the metabolic and immunological heterogeneity of prostate cancer and provide a novel metabolism-based prognostic model. Targeting tumor metabolism may enhance immune responses and improve risk stratification and therapeutic outcomes in PCa patients.
Authors
- Yuanting Liu (ORCID: https://orcid.org/0000-0002-8651-6272)
- Yixiao Shi
- Yujie Cao (ORCID: https://orcid.org/0000-0002-1014-6578)
- Yuchun Zhu (ORCID: https://orcid.org/0000-0002-6140-2586)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1007/s12672-025-03269-6
- Citations
- 1
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94